title: Amiodarone and acetazolamide for the treatment of genetically confirmed severe Andersen syndrome.
authors.affiliation: Department of Neurology, Universitätsklinikum Münster, D-48129 Münster, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Junker
authors.forename: W
authors.initials: W
authors.lastname: Haverkamp
authors.forename: E
authors.initials: E
authors.lastname: Schulze-Bahr
authors.forename: L
authors.initials: L
authors.lastname: Eckardt
authors.forename: W
authors.initials: W
authors.lastname: Paulus
authors.forename: R
authors.initials: R
authors.lastname: Kiefer
mesh_terms: D000086:Acetazolamide / Q000627:therapeutic use*; D000293:Adolescent; D000638:Amiodarone / Q000627:therapeutic use*; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000927:Anticonvulsants / Q000627:therapeutic use; D002648:Child; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy* / Q000235:genetics* / Q000503:physiopathology; D010245:Paralyses, Familial Periodic / Q000188:drug therapy* / Q000235:genetics*
chemical_list: D000889:Anti-Arrhythmia Agents; D000927:Anticonvulsants; D000638:Amiodarone; D000086:Acetazolamide